ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $367,362 | -8.4% | 33,549 | +10.8% | 0.01% | -18.2% |
| Q2 2023 | $400,920 | +111.4% | 30,281 | +117.3% | 0.01% | +120.0% |
| Q1 2023 | $189,628 | -62.8% | 13,933 | -43.7% | 0.01% | -78.3% |
| Q2 2022 | $510,000 | +6.9% | 24,738 | +66.9% | 0.02% | +4.5% |
| Q1 2022 | $477,000 | -27.8% | 14,824 | -42.5% | 0.02% | -60.7% |
| Q2 2021 | $661,000 | – | 25,778 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
| Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
| 683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
| Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
| DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |